These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4629915)

  • 41. [Practical experiences with the anti-D-IgG prevention of Rh-immunization].
    Bergmann H; Leinzinger E; Pazdernik I; Haider M
    Wien Med Wochenschr; 1969 Jan; 119(1):9-12. PubMed ID: 4975236
    [No Abstract]   [Full Text] [Related]  

  • 42. Rh immunoglobulin in prevention of hemolytic disease of newborn child.
    Gorman JG
    N Y State J Med; 1983 Jan; 83(1):42-9. PubMed ID: 6402737
    [No Abstract]   [Full Text] [Related]  

  • 43. [Significance of weak D antigens of the Rh system in blood transfusion and in the immunopathology of pregnancy].
    Frankowska K
    Pol Tyg Lek; 1969 Feb; 24(6):206-8. PubMed ID: 4976145
    [No Abstract]   [Full Text] [Related]  

  • 44. [Immunization in the range of HL-A antigen system in volunteers immunized with small doses of blood incompatible in the Rh system].
    Maczyńska-Rusiniak B; Zupańska B
    Acta Haematol Pol; 1975; 6(4):253-60. PubMed ID: 812324
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic abortion as a possible source of Rh immunization.
    Hollán SR; Szelényi JG; Sötér VN; Hasitz M
    Acta Med Acad Sci Hung; 1970; 27(3):337-40. PubMed ID: 4995192
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F; Dallavalle FM
    Arch Sci Med (Torino); 1980; 137(4):563-5. PubMed ID: 6788016
    [No Abstract]   [Full Text] [Related]  

  • 47. Rh isoimmunization related to amniocentesis.
    Murray JC; Karp LE; Williamson RA; Cheng EY; Luthy DA
    Am J Med Genet; 1983 Dec; 16(4):527-34. PubMed ID: 6419606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-e found in a case of hemolytic disease of the fetus and newborn make use of the IGHV3 superspecies genes.
    Dohmen SE; Muit J; Ligthart PC; Verhagen OJ; van der Schoot CE
    Transfusion; 2008 Jan; 48(1):194-5. PubMed ID: 18184235
    [No Abstract]   [Full Text] [Related]  

  • 49. [Family differencies in the the prognosis of rhesus iso-immunization].
    Polácek K
    Gynaecologia; 1969; 168(2):109-16. PubMed ID: 4981912
    [No Abstract]   [Full Text] [Related]  

  • 50. [Serum complement in hemolytic disease of the newborn].
    Gravina E; Gravina-Sanvitale G
    Minerva Pediatr; 1971 Feb; 23(5):199-203. PubMed ID: 4995757
    [No Abstract]   [Full Text] [Related]  

  • 51. A review of the production and clinical use of intravenous Anti-D immunoglobulin.
    Walsh TJ; O'Riordan JP
    Ir Med J; 1982 Jul; 75(7):243-4. PubMed ID: 6813287
    [No Abstract]   [Full Text] [Related]  

  • 52. [Relationship between compatible and incompatible isoantigenic combinations by type-specific (RHESUS) AND GROUP (ABO) blood antigens in dead fetuses at different stages of development, dead newborn infants and their mothers].
    Andreeva EI
    Pediatriia; 1975 May; (5):23-6. PubMed ID: 806884
    [No Abstract]   [Full Text] [Related]  

  • 53. [Protective mechanisms in hemolytic disease of the newborn. (Rhesus system)].
    Gonzalez Ramos M
    Ginecol Obstet Mex; 1966; 21(123):469-75. PubMed ID: 4967226
    [No Abstract]   [Full Text] [Related]  

  • 54. [Immune-prevention of fetal erythroblastosis].
    Schubert W
    Z Arztl Fortbild (Jena); 1971 Jun; 65(11):540-5. PubMed ID: 4998879
    [No Abstract]   [Full Text] [Related]  

  • 55. [Conditions of the prevention of neonatal hemolytic diseases resulting from Rh(D) incompatibility in Hungary].
    Simonovits I; Garancsy L; Böröcz I
    Orv Hetil; 1980 Apr; 121(15):875-8. PubMed ID: 6770319
    [No Abstract]   [Full Text] [Related]  

  • 56. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The danger of sensitization by miscarriages].
    Krebs D
    Bibl Haematol; 1969; 32():141-3. PubMed ID: 4980800
    [No Abstract]   [Full Text] [Related]  

  • 58. [Hematologic diagnosis of hemolytic disease of the newborn].
    Martín Villar J; Navarro Navarro JL
    Acta Obstet Ginecol Hisp Lusit; 1968; 16(4):285-93. PubMed ID: 4988904
    [No Abstract]   [Full Text] [Related]  

  • 59. Management of a full-term infant with hemolytic disease of the newborn due to an anti-Rh17 antibody in a mother with D-- phenotype.
    Shah SI; Caprio M; Strauss R; Moskowitz N
    Am J Hematol; 2005 Sep; 80(1):88-9. PubMed ID: 16138349
    [No Abstract]   [Full Text] [Related]  

  • 60. Hemolytic disease of the newborn. A new law for prenatal blood test and disease reporting.
    Saylor LF
    Calif Med; 1970 Feb; 112(2):79. PubMed ID: 4990381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.